Literature DB >> 6186875

5-azacytidine for beta-thalassemia?

J B Clegg, D J Weatherall, W F Bodmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6186875     DOI： 10.1016/s0140-6736(83)92227-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Hematological responses to hydroxyurea therapy in multitransfused thalassemic children.

Authors:  V P Choudhry; A Lal; H P Pati; L S Arya
Journal:  Indian J Pediatr       Date:  1997 May-Jun       Impact factor: 1.967

2.  Gene switching -- a new therapeutic epoch: discussion paper.

Authors:  R M Nalbandian; G C Cypress
Journal:  J R Soc Med       Date:  1984-03       Impact factor: 5.344

3.  BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

Authors:  Lei Yu; Natee Jearawiriyapaisarn; Mary P Lee; Tomonori Hosoya; Qingqing Wu; Greggory Myers; Kim-Chew Lim; Ryo Kurita; Yukio Nakamura; Anne B Vojtek; Jean-François Rual; James Douglas Engel
Journal:  Genes Dev       Date:  2018-11-21       Impact factor: 11.361
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.